Tumour virus infections articles within Nature

Featured

  • Article |

    An analysis of human papillomavirus (HPV)-specific CD8 T cells in patients with head and neck cancer identifies functional PD-1+TCF-1+CD8 T cells in the tumour with implications for therapeutic vaccination and PD-1 directed immunotherapy.

    • Christiane S. Eberhardt
    • , Haydn T. Kissick
    •  & Rafi Ahmed
  • Article |

    A mouse model of papillomavirus infection reveals that skin colonization with commensal papillomaviruses protects the immunocompetent host against chemical- and UV-induced skin cancer through CD8+ T cell immunity.

    • John D. Strickley
    • , Jonathan L. Messerschmidt
    •  & Shadmehr Demehri
  • Outlook |

    Human papillomavirus (HPV) has become synonymous with cervical cancer, but its actual footprint is much bigger, by James Mitchell Crow.

    • James Mitchell Crow
  • Outlook |

    Two vaccines seem to be so effective in preventing HPV infection that mass vaccination has been introduced for girls. But will long-term studies show falls in cervical cancer?

    • Julie Clayton
  • Outlook |

    Linking specific types of HPV with cervical cancer and developing effective vaccines against should be celebrated. But there are gaps in our understanding of these viruses and how they cause disease.

    • Laura Vargas-Parada
  • Outlook |

    A Nobel prizewinner for pinning cervical cancer on human papillomavirus, Harald zur Hausen still investigates viruses. Nature Outlook talks to the medical doctor–turned–virologist about other possible culprits.

    • Harald zur Hausen
  • Outlook |

    Vaccines on the market aren't practical for the developing world — where cervical cancer hits hardest — but researchers are trying to make ones that are.

    • Katharine Sanderson
  • Outlook |

    HPV-associated cancers in men are on the rise. By not vaccinating boys we are failing to gain maximum health benefit, argues Margaret Stanley.

    • Margaret Stanley
  • Outlook |

    Sub-Saharan countries lag behind in screening and treatment for human papillomavirus. But national efforts and the introduction of low-tech methods could change that.

    • Michael Eisenstein